• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Saliva identifies head and neck cancers

Article

The RNA in saliva contains biomarkers that can accurately differentiate between patients with head and neck cancers and healthy controls.

The RNA in saliva contains biomarkers that can accurately differentiate between patients with head and neck cancers and healthy controls.

Saliva contains the same biomarkers for disease found in blood but present at much lower levels of magnitude. Nanotechnology has allowed scientists for the first time to manipulate materials on an atomic or molecular scale, thus uncovering the components of saliva.

Dr. Li Yang and colleagues at the University of California, Los Angeles evaluated 32 patients with primary T1/T2 oral squamous cell carcinoma. Location of cancers included the mouth, tongue, larynx, and pharynx. Thirty-two control subjects without cancer but with the same smoking history were also enrolled.

Microarray analysis of saliva showed more than 1600 genes that exhibited significantly different expression levels in saliva between cancer patients and controls. Seven cancer-related RNA biomarkers were consistently elevated in the cancer patients.

The combinations of these biomarkers yielded 91% sensitivity and specificity in distinguishing cancer patients from the controls. The study appeared in the Dec. 15, 2004, issue of Clinical Cancer Research.

"This is a new direction, using a noninvasive fluid for disease diagnostics, particularly in cancer," said coauthor Dr. David Wong, director of the UCLA Dental Research Institute. "This is our proof of principle. We now hope to demonstrate the utility of saliva for systemic diagnosis of other diseases such as breast cancer."

For more information from the Diagnostic Imaging archives:

Protein profiles reflect MRI contrast patterns

Wing of newt competes with tested agents

Vijay Rao presses for excellence

MRI and CT provide salivary gland details

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.